Dr. Allison on His Early Career at The University of Texas MD Anderson Cancer Center

Video

In Partnership With:

James P. Allison, PhD, discusses his early career at The University of Texas MD Anderson Cancer Center.

James P. Allison, PhD, chair, Immunology, executive director, Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, and a recipient of the 2018 Nobel Prize in Physiology or Medicine, discusses his early career at The University of Texas MD Anderson Cancer Center.

Allison completed his first faculty appointment at The University of Texas MD Anderson Cancer Center. He had an early interest in immunology and T cells, which first began to be recognized in the late 1960s, according to Allison. As a biochemist, Allison decided that he wanted to focus his research efforts on T cells were, but he did not receive the chance to until his faculty appointment at MD Anderson, Allison says.

Allison finished his postdoctoral research at an immunology lab, where he did protein purification. When he arrived at MD Anderson, he was able to indulge his curiosity and work out the structure of the T-cell antigen receptor, which propelled him into his subsequent research, Allison concludes.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD